Find articles of interest based on keywords and names, just click the most
popular links below to access the relevant articles.
The Clinical research facility is part of the NIHR and is funded by the Department of Health
Home > ac220
A phase 2 open label, AC220 monotherapy efficacy study in patients with acute myeloid leukaemia (AML) with FLT3-ITD activating mutations.